Table 3.

Treatment compliance and persistency of the patients in the study groups.

	AT group n (%)	PT group n (%)	p value
Patients who received bisphosphonate treatment
Visit 2	210 (49.8)	212 (50.2)	0.922
Visit 3	191 (50.8)	185 (49.2)	0.759
Visit 4	175 (49.1)	178 (50.9)	0.747
Visit 5	152 (50.5)	149 (49.5)	0.862
Patients who received bisphosphonate treatment at the exact day
Visit 2	122 (53.7)	105 (46.3)	0.261
Visit 3	115 (56.6)	83 (43.4)	0.068
Visit 4	110 (51.2)	105 (48.8)	0.734
Visit 5	104 (51.7)	97 (48.3)	0.622
Patients who did not receive bisphosphonate treatment at the exact day
Visit 2	88 (45.1)	107 (54.9)	0.176
Visit 3	76 (42.7)	102 (57.3)	0.054
Visit 4	60 (45.8)	71 (54.8)	0.305
Visit 5	50 (48.5)	53 (51.5)	0.766
Patients who did not complete bisphosphonate dose
Visit 2	31 (50.0)	31 (50.0)	1.000
Visit 3	31 (47.7)	34 (52.3)	0.710
Visit 4	22 (53.7)	19 (46.3)	0.640
Visit 5	14 (43.8)	18 (56.2)	0.484

AT, Active Training; PT, Passive Training.